DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 4Dr. Reddy's Laboratories
02 8Accord healthcare
03 1Aurobindo Pharma Limited
04 27Boehringer Ingelheim GmbH
05 2Captavis Biocare
06 1Cipla
07 2Eignapharma S.L.
08 2Eignapharma Sl
09 2Eugia Pharma
10 1Glenmark Pharmaceuticals
11 2Intas Pharmaceuticals
12 4Lotus Pharma Bulgaria Eood
13 2Lotus Pharmaceutical
14 2Newbury Pharmaceuticals Ab
15 2Olon S.p.A
16 4STADA Arzneimittel
17 4Sandoz B2B
18 6Teva Pharmaceutical Industries
19 2Zentiva
01 2CAP
02 5CAPSULE
03 8CAPSULE;ORAL
04 27Capsule
05 5Capsule, soft
06 1Nintedanib 100Mg 60 Units Oral Use
07 1Nintedanib 150Mg 60 Units Oral Use
08 2Oral Solid Dosage Form
09 19Soft Capsule
10 2Soft Gel
11 2Soft Gelatin Capsule
12 4Blank
01 25Approved
02 19Authorized
03 1Available Dossier- US-EU-RoW
04 2Lead Market Dossiers- Under Development
05 2Originator
06 2Prescription
07 2RX
08 25Blank
01 9NINTEDANIB
02 2Nifibro
03 4Nintedanib Accord
04 2Nintedanib Accordpharma
05 4Nintedanib Eignapharma
06 2Nintedanib Eugia
07 2Nintedanib Lotus
08 2Nintedanib Newbury
09 2Nintedanib Reddy
10 4Nintedanib Sandoz
11 4Nintedanib Stada
12 4Nintedanib Teva
13 2Nintedanib Zentiva
14 4OFEV
15 14Ofev
16 1Ofev 100 mg
17 1Ofev 150 mg
18 5Vargatef
19 2Wolff
20 8Blank
01 4Australia
02 2Canada
03 6India
04 4Italy
05 5Norway
06 2South Africa
07 19Spain
08 25Sweden
09 11USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Nintedanib Reddy
Dosage Form : Capsule
Dosage Strength : 100mg
Packaging :
Approval Date : 12/06/2025
Application Number : 20240229000113
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Nintedanib Reddy
Dosage Form : Capsule
Dosage Strength : 150mg
Packaging :
Approval Date : 12/06/2025
Application Number : 20240229000120
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date :
Application Number : 212732
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date :
Application Number : 212732
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date :
Application Number : 215123
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OFEV
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2014-10-15
Application Number : 205832
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OFEV
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2014-10-15
Application Number : 205832
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Ofev
Dosage Form : Nintedanib 100Mg 60 Units Oral Use
Dosage Strength : 1x60 soft cps 100 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Ofev
Dosage Form : Nintedanib 150Mg 60 Units Oral Use
Dosage Strength : 1x60 soft cps 150 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Ofev
Dosage Form : Capsule, soft
Dosage Strength : 100 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Ofev
Dosage Form : Capsule, soft
Dosage Strength : 150 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Vargatef
Dosage Form : Capsule, soft
Dosage Strength : 100 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 212609
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date :
Application Number : 212555
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 216915
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number : 216915
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 219371
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number : 219371
Regulatory Info :
Registration Country : USA
